Skip to content
Clinical Trials – home
Region Midtjylland
Sponsor

Region Midtjylland

Denmark Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark

About the sponsor

Research activity includes coronary artery disease, heart failure, aortic stenosis, hypertrophic cardiomyopathy, myocardial infarction, cardiac arrest, and covert brain infarction, with additional interest in type 1 diabetes, type 2 diabetes, prediabetes, obesity, insulin resistance, and non-alcoholic fatty liver disease.

  • Heart disease and cardiac imaging
  • Cardio-renal protection
  • Glucose-lowering therapies
  • Cardiometabolic risk reduction

The sponsor also supports work on cardiovascular prevention, vascular events, and renal protection in patients with overlapping metabolic and cardiac conditions.

About Specializations

Region Midtjylland runs clinical trials in conditions such as HIV infection, Chronic kidney disease, Turner's syndrome, Enuresis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

78 clinical trials

A study to compare continuous infusion and intermittent injections of furosemide and amiloride hydrochloride in patients hospitalized with acute heart failure and fluid overload

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Region Midtjylland

A study of progesterone after letrozole treatment for women with infertility undergoing intrauterine insemination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Progesterone
  • Sponsor:Region Midtjylland

A study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic adipose-derived mesenchymal stem cells in vitro expanded
  • Sponsor:Region Midtjylland

Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Levothyroxine
  • Sponsor:Region Midtjylland

A study comparing different zinc doses for the treatment of Wilson disease in healthy participants.

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Copper (64CU) chloride
  • Sponsor:Region Midtjylland

HIV infection

Recruiting

A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Venetoclax
  • Sponsor:Region Midtjylland

Study of dapagliflozin and semaglutide to reverse prediabetes to normal blood sugar levels in patients with coronary artery disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Region Midtjylland

Migraine

Recruiting

A Study Testing Cabergoline to Prevent and Treat Episodic Migraine in Patients with Recurring Migraine Headaches

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cabergoline
  • Sponsor:Region Midtjylland
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Region Midtjylland

Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Region Midtjylland

Comparison of ivabradine, atenolol, and metoprolol for heart rate control in patients with ischemic heart disease before cardiac CT examination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Atenolol
  • Sponsor:Region Midtjylland

Study of semaglutide and finerenone for kidney and blood vessel protection in adults with chronic kidney disease, with or without diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Region Midtjylland

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.